Trial intelligence / Profile preview

Baclofen efficacy in GERD patients with versus without hiatal hernia

NL-OMON23260Active, not recruiting

Sponsor
Academic Medical Center
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of baclofen in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Academic Medical Center. Primary endpoint: Number of reflux episodes over 24 hours. Started Mar 2007; status: active, not recruiting.

02

Drugs

baclofen
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NL-OMON23260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON23260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call